SUCCESSFUL USE OF CRUSHED FORMULATION OF DABRAFENIB AND
TRAMETINIB IN A PEDIATRIC GLIONEURAL TUMOR
Tania Mamdouhi1, Anshul Vagrecha2,
Alan A. Johnson1,3, Carolyn Fein
Levy1,2, Mark Atlas 1,2, Julie I.
Krystal 1,2
1 Zucker School of Medicine at Hofstra/Northwell,
Hempstead, NY
2 Department of Pediatrics, Division of
Hematology/Oncology and Cellular Therapy, Cohen Children’s Medical
Center, New Hyde Park, NY
3 Department of Radiology, Division of Neuroradiology,
Long Island Jewish Medical Center, New Hyde Park, NY
Corresponding Author : Julie Krystal. Cohen Children’s Medical
Center, 269- 01 76th Avenue, Suite 255, New Hyde Park,
NY 11040.
Jkrystal12@northwell.edu. Phone
718-470-3460. Fax 718-343-4642.
Tables: 0
Figures: 1
Supporting Information Files : 0
Short running title: Use of crushed formulation of dabrafenib
and trametinib
Keywords : Dabrafenib, Trametinib, BRAF, crushed
Data Availability: The data that support the findings of this
study are available from the corresponding author upon reasonable
request.